CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+3.96%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$9.24B
AUM Growth
+$9.24B
(+5.3%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
60.06%
Holding
93
New
8
Increased
13
Reduced
25
Closed
4
Top Buys
| 1 |
Parker-Hannifin
PH
|
$228M |
| 2 |
Clean Harbors
CLH
|
$33.1M |
| 3 |
HDFC Bank
HDB
|
$21.1M |
| 4 |
Tencent Music
TME
|
$20.8M |
| 5 |
Ferguson
FERG
|
$19.1M |
Top Sells
| 1 |
Dropbox
DBX
|
$44.8M |
| 2 |
Microsoft
MSFT
|
$15.7M |
| 3 |
Waters Corp
WAT
|
$14.3M |
| 4 |
Amazon
AMZN
|
$12.6M |
| 5 |
Thermo Fisher Scientific
TMO
|
$11.7M |
Sector Composition
| 1 | Technology | 21.29% |
| 2 | Financials | 18.61% |
| 3 | Healthcare | 16.24% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medtronic
MDT
$118B
| $22.8M | 0.25% |
290,000
| – | – |
|
52
Sea Limited
SE
$107B
| $22.7M | 0.25% |
317,298
-1,119
| -0.4% | -$79.9K |
|
53
Centene
CNC
$14.8B
| $22.2M | 0.24% |
334,756
| – | – |
|
54
Sarepta Therapeutics
SRPT
$1.98B
| $22.2M | 0.24% |
140,329
| – | – |
|
55
Glaukos
GKOS
$5.42B
| $21M | 0.23% |
177,212
-20,000
| -10% | -$2.37M |
|
|
56
Tencent Music
TME
$38.5B
| $20.8M | 0.22% |
+1,478,477
| New | +$20.8M |
|
57
Humana
HUM
$37.5B
| $19.6M | 0.21% |
52,459
| – | – |
|
58
Penumbra
PEN
$10.5B
| $17.5M | 0.19% |
97,000
+20,000
| +26% | +$3.6M |
|
59
Infosys
INFY
$69B
| $15.8M | 0.17% |
850,549
+31,826
| +4% | +$593K |
|
60
Align Technology
ALGN
$9.59B
| $15.3M | 0.17% |
63,428
| – | – |
|
61
Ionis Pharmaceuticals
IONS
$9.64B
| $14.3M | 0.15% |
300,000
| – | – |
|
62
Teleflex
TFX
$5.57B
| $12.2M | 0.13% |
58,000
| – | – |
|
63
Privia Health
PRVA
$2.84B
| $10.6M | 0.11% |
610,000
| – | – |
|
64
Neurocrine Biosciences
NBIX
$13.5B
| $10.3M | 0.11% |
+75,000
| New | +$10.3M |
|
65
Iovance Biotherapeutics
IOVA
$800M
| $10.1M | 0.11% |
1,260,000
+200,000
| +19% | +$1.6M |
|
66
NovoCure
NVCR
$1.35B
| $8.94M | 0.1% |
521,784
| – | – |
|
67
Zai Lab
ZLAB
$3.48B
| $8.67M | 0.09% |
+500,000
| New | +$8.67M |
|
68
iRhythm Technologies
IRTC
$5.67B
| $8.61M | 0.09% |
80,000
| – | – |
|
69
Illumina
ILMN
$15.2B
| $8.14M | 0.09% |
77,978
| – | -$228K |
|
70
Outset Medical
OM
$245M
| $3.85M | 0.04% |
1,000,000
| – | – |
|
71
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $3.34M | 0.04% |
1,928,464
| – | – |
|
72
McKesson
MCK
$85.9B
| $2.53M | 0.03% |
4,332
| – | – |
|
73
Amdocs
DOX
$9.31B
| $2.16M | 0.02% |
27,400
+7,120
| +35% | +$562K |
|
74
OR Royalties Inc.
OR
$6.27B
| $2.02M | 0.02% |
129,747
+42,486
| +49% | +$662K |
|
75
Brookfield Renewable
BEPC
$5.92B
| $2M | 0.02% |
70,545
-44,191
| -39% | -$1.25M |
|